Pradaxa® is oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant (“blood thinner”) since it does not require frequent blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.  It was developed by Boehringer Ingelheim.  http://www.boehringer-ingelheim.com/

Pradaxa® was approved by the FDA in October 2010 for stroke prevention in patients with atrial fibrillation. It is the first of a new crop of blood

Surgical mesh is a medical device that is generally used to repair weakened or damaged tissue.  It is made from porous absorbable or non-absorbable synthetic material or absorbable biologic material.  Surgical mesh can be used for urogynecologic procedures, including repair of pelvic organ prolapse “(POP”) and stress urinary incontinence (“SUI”).  It is permanently implanted to reinforce the weakened vaginal wall for POP repair or support the urethra or bladder neck for the repair of SUI.

When women suffer from POP or of SUI, they often seek treatment.  One of the most popular

• John Poulos was recently appointed as an arbitrator for contract disputes by Presiding Judge David F. Bauman of the New Jersey Superior Court, Monmouth County.